These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2032 related items for PubMed ID: 23672175

  • 1. [Biologics and mycobacterial diseases].
    Tsuyuguchi K, Matsumoto T.
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [Abstract] [Full Text] [Related]

  • 2. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S, Nagai H.
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [Abstract] [Full Text] [Related]

  • 3. [Evolution of IGRA researches].
    Ariga H, Harada N.
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [Abstract] [Full Text] [Related]

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 5. [Lessons learned from tuberculosis outbreak cases].
    Kato S, Kuwabara K.
    Kekkaku; 2014 Feb; 89(2):77-88. PubMed ID: 24716362
    [Abstract] [Full Text] [Related]

  • 6. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T, Yamazaki T.
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [Abstract] [Full Text] [Related]

  • 7. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N.
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [Abstract] [Full Text] [Related]

  • 8. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M.
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [Abstract] [Full Text] [Related]

  • 9. [Exogenous re-infection in tuberculosis].
    Tsuchiya T.
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [Abstract] [Full Text] [Related]

  • 10. Treatment guidelines for latent tuberculosis infection.
    Prevention Committee of the Japanese Society for Tuberculosis, Treatment Committee of the Japanese Society for Tuberculosis.
    Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
    [Abstract] [Full Text] [Related]

  • 11. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K, Sano C.
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [Abstract] [Full Text] [Related]

  • 12. [Follow-up discussion on restructuring the medical-service system].
    Kato S, Kamada A.
    Kekkaku; 2012 Dec; 87(12):809-19. PubMed ID: 23350522
    [Abstract] [Full Text] [Related]

  • 13. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A.
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [Abstract] [Full Text] [Related]

  • 14. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 15. [Patient-centered medicine for tuberculosis medical services].
    Fujita A, Narita T.
    Kekkaku; 2012 Dec; 87(12):795-808. PubMed ID: 23350521
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
    Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M, BIOBADASER Group.
    Arthritis Rheum; 2005 Jun; 52(6):1766-72. PubMed ID: 15934089
    [Abstract] [Full Text] [Related]

  • 17. [Reform of Japan's NTP and its technical perspectives].
    Mori T.
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [Abstract] [Full Text] [Related]

  • 18. [Reconsideration of the admission and discharge criteria of tuberculosis patients in Japan].
    Masuyama H, Igari H.
    Kekkaku; 2013 Mar; 88(3):373-85. PubMed ID: 23672177
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M, Nakajima Y.
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [Abstract] [Full Text] [Related]

  • 20. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M.
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 102.